{"archive_url":"https://www.ebi.ac.uk/ega/datasets/EGAD00001002411","experiment":{"EXPERIMENT_TYPE":"Histone H3K27ac","EXPERIMENT_ID":"EGAX00001304989","attributes":{"EXTRACTION_PROTOCOL_SONICATION_CYCLES":["20 min; 30 sec ON/ 30 sec OFF"],"CHIP_ANTIBODY":["H3K27ac"],"CHIP_PROTOCOL_BEAD_TYPE":["magnetic beads A and G"],"EXPERIMENT_TYPE":["Histone H3K27ac"],"CHIP_PROTOCOL_BEAD_AMOUNT":["20  ul"],"CHIP_ANTIBODY_CATALOG":["BP grade"],"CHIP_ANTIBODY_LOT":["A1723-0041d"],"CHIP_PROTOCOL_ANTIBODY_AMOUNT":["1,0  ug"],"CHIP_PROTOCOL_CHROMATIN_AMOUNT":["1x 500.000 cells = 33  ul"],"EXTRACTION_PROTOCOL":["Chromatin was extracted using the histone protocol. Cells are crosslinked at 4 degrees 16 min in 1% formaldehyde. Washed twice in PBS and dissolved in shearing buffer (containing 1% SDS), such that the final concentration is 15*10^6 cells/ml."],"CHIP_PROTOCOL":["Protocol July 2014: 500.000 cells per ChIP. Overnight incubation of chromatin with antibody. 1 hour incubation in the morning with A/G magnetic beads. Wash once with buffer 1, and twice with buffer 2 and 3 at 4 degrees. Elute 20 min with elution buffer at RT. Descrosslink 4 hours at 65 degrees. Purify by column purification."],"LIBRARY_GENERATION_FRAGMENT_SIZE_RANGE":["219"],"CHIP_ANTIBODY_PROVIDER":["Diagenode"],"EXTRACTION_PROTOCOL_TYPE_OF_SONICATOR":["Bioruptor Plus (UCD-300)"]},"ASSAY_TYPE":"ChIP-Seq"},"archive":"EGA","ftp_path":"http://ftp.ebi.ac.uk/pub/databases/blueprint/data/homo_sapiens/GRCh38/venous_blood/MS49/T-cell_Prolymphocytic_Leukemia/ChIP-Seq/NCMLS","files":[{"FORMAT":"bigBed","SIZE":"2.3M","NAME":"S0145XH1.ERX1007389.H3K27ac.bwa.GRCh38.20151015.bb","FILE_TYPE":"CHIP_MACS2_BB","ANALYSIS_GROUP":"EMBL-EBI","TYPE":"Enriched regions","PATH":"http://ftp.ebi.ac.uk/pub/databases/blueprint/data/homo_sapiens/GRCh38/venous_blood/MS49/T-cell_Prolymphocytic_Leukemia/ChIP-Seq/NCMLS/S0145XH1.ERX1007389.H3K27ac.bwa.GRCh38.20151015.bb","PROTOCOL_DOC":"chip_seq_grch38","MD5":"987b9f4dbdb2fbce24a7b221ebf842c2"},{"FORMAT":"BED","SIZE":"2.3M","NAME":"S0145XH1.ERX1007389.H3K27ac.bwa.GRCh38.20151015.bed.gz","FILE_TYPE":"CHIP_MACS2_BED","ANALYSIS_GROUP":"EMBL-EBI","TYPE":"Enriched regions","PATH":"http://ftp.ebi.ac.uk/pub/databases/blueprint/data/homo_sapiens/GRCh38/venous_blood/MS49/T-cell_Prolymphocytic_Leukemia/ChIP-Seq/NCMLS/S0145XH1.ERX1007389.H3K27ac.bwa.GRCh38.20151015.bed.gz","PROTOCOL_DOC":"chip_seq_grch38","MD5":"e319f97501506ebcc7f7dc2fd4cf4b34"},{"FORMAT":"Text","SIZE":"2.8M","NAME":"S0145XH1.ERX1007389.H3K27ac.bwa.GRCh38.20151015.xls.gz","FILE_TYPE":"CHIP_MACS2_BED","ANALYSIS_GROUP":"EMBL-EBI","TYPE":"Enriched regions","PATH":"http://ftp.ebi.ac.uk/pub/databases/blueprint/data/homo_sapiens/GRCh38/venous_blood/MS49/T-cell_Prolymphocytic_Leukemia/ChIP-Seq/NCMLS/S0145XH1.ERX1007389.H3K27ac.bwa.GRCh38.20151015.xls.gz","PROTOCOL_DOC":"chip_seq_grch38","MD5":"1899714011301ea8ef5f574397943e70"},{"FORMAT":"bigWig","SIZE":"590M","NAME":"S0145XH1.ERX1007389.H3K27ac.bwa.GRCh38.20151029.bw","FILE_TYPE":"CHIP_WIGGLER","ANALYSIS_GROUP":"EMBL-EBI","TYPE":"Normalized signal","PATH":"http://ftp.ebi.ac.uk/pub/databases/blueprint/data/homo_sapiens/GRCh38/venous_blood/MS49/T-cell_Prolymphocytic_Leukemia/ChIP-Seq/NCMLS/S0145XH1.ERX1007389.H3K27ac.bwa.GRCh38.20151029.bw","PROTOCOL_DOC":"chip_seq_grch38","MD5":"feb1d886946df8a2b76b94e1091a0cc9"}],"dataset_id":"EGAD00001002411","sample":{"SAMPLE_SOURCE":"venous blood","SAMPLE_NAME":"MS49","sample_barcode":"S0145XH1","attributes":{"DONOR_HEALTH_STATUS":["T-cell Prolymphocytic Leukemia"],"DONOR_AGE":["NA"],"MOLECULE":["genomic DNA"],"DISEASE":["T-cell Prolymphocytic Leukemia"],"BIOMATERIAL_PROVIDER":["Anke Bergmann"],"BIOMATERIAL_TYPE":["Primary Tissue"],"TISSUE_TYPE":["venous blood"],"DISEASE_ONTOLOGY_URI":[{"url":"2","label":"C2363142"}],"SAMPLE_ONTOLOGY_URI":[{"url":"6","label":"UBERON_0013756"}],"GENDER":["female"],"DONOR_ID":["MS49"],"DONOR_SEX":["Female"],"COLLECTION_METHOD":["Venipuncture"],"DONOR_ETHNICITY":["NA"],"TISSUE_DEPOT":["NA"]},"SAMPLE_ID":"EGAN00001277489","SAMPLE_DESCRIPTION":"T-cell Prolymphocytic Leukemia"}}